Related references
Note: Only part of the references are listed.Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats
Hiroshi Murayama et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Impaired Tubular Uptake Explains Albuminuria in Early Diabetic Nephropathy
Leileata M. Russo et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Comparative Analysis of Novel Noninvasive Renal Biomarkers and Metabonomic Changes in a Rat Model of Gentamicin Nephrotoxicity
Max Sieber et al.
TOXICOLOGICAL SCIENCES (2009)
Strategic approach to fit-for-purpose biomarkers in drug development
John A. Wagner
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes
Kazuhiko Ikeda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Urine NGAL predicts severity of acute kidney injury after cardiac surgery: A prospective study
Michael Bennett et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Biomarkers in oncology drug development: rescuers or troublemakers?
Estelle Marrer et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: Are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine?
H. Bachorzewska-Gajewska et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
The circulating inactive form of matrix Gla protein (ucMGP) as a biomarker for cardiovascular calcification
Ellen C. M. Cranenburg et al.
JOURNAL OF VASCULAR RESEARCH (2008)
The current state of serum biomarkers of hepatotoxicity
Josef Ozer et al.
TOXICOLOGY (2008)
Monitoring liver safety in drug development: The GSK experience
Christine M. Hunt et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2007)
Investigation of the molecular mechanisms preceding PDE4 inhibitor-induced vasculopathy in rats:: Tissue inhibitor of metalloproteinase 1, a potential predictive biomarker
Nicolas Dagues et al.
TOXICOLOGICAL SCIENCES (2007)
Urinary N-acetyl-β-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure
Orfeas Liangos et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Biomarkers to monitor drug-induced phospholipidosis
Elizabeth Tengstrand Baronas et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Biomarker qualification pilot process at the US food and drug administration
Federico Goodsaid et al.
AAPS JOURNAL (2007)
Novel insights into vascular calcification
M. Ketteler et al.
KIDNEY INTERNATIONAL (2006)
An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease
Mark A. Giembycz
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Drug-induced phospholipidosis: issues and future directions
Mark J. Reasor et al.
EXPERT OPINION ON DRUG SAFETY (2006)
Induced secretion of tissue inhibitor of metalloproteinases-1 (TIMP-1) in vivo and in vitro by hepatotoxin rubratoxin B
H. Nagashima et al.
FOOD AND CHEMICAL TOXICOLOGY (2006)
Urinary cystatin C as a specific marker of tubular dysfunction
M Conti et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury
VS Vaidya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Fit-for-purpose method development and validation for successful biomarker measurement
JW Lee et al.
PHARMACEUTICAL RESEARCH (2006)
Biomarkers of acute renal injury and renal failure
Ronald J. Trof et al.
SHOCK (2006)
Drug-induced glomerulopathies
H Izzedine et al.
EXPERT OPINION ON DRUG SAFETY (2006)
Renal tubular toxicity associated with tenofovir assessed using urine-beta 2 microglobulin, percentage of tubular reabsorption of phosphate and alkaline phosphatase levels
E Kinai et al.
AIDS (2005)
Assessment of effective renal plasma flow, enzymuria, and cytokine release in healthy volunteers receiving a single dose of amphotericin B desoxycholate
MP Pai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: A marker predictive of cardiac dysfunction?
MT Sandri et al.
CLINICAL CHEMISTRY (2005)
Idiosyncratic drug hepatotoxicity
N Kaplowitz
NATURE REVIEWS DRUG DISCOVERY (2005)
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery
J Mishra et al.
LANCET (2005)
Statins and hepatotoxicity: Focus on patients with fatty liver
N Chalasani
HEPATOLOGY (2005)
Drug-induced vascular injury - a quest for biomarkers
W Kerns et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
A toxicogenomic approach to drug-induced phospholipidosis:: Analysis of its induction mechanism and establishment of a novel in vitro screening system
H Sawada et al.
TOXICOLOGICAL SCIENCES (2005)
Liver enzyme alteration: a guide for clinicians
EG Giannini et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
The toxicity of SCH 351591, a novel phosphodiesterase-4 inhibitor, in cynomolgus monkeys
PE Losco et al.
TOXICOLOGIC PATHOLOGY (2004)
Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model
J Delaney et al.
BIOMARKERS (2004)
Troponin-T and brain natriuretic peptide as predictors for adriamycin-induced cardiomyopathy in rats
E Koh et al.
CIRCULATION JOURNAL (2004)
Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology
AEM Vickers et al.
TOXICOLOGIC PATHOLOGY (2004)
Differential type 4 cAMP-specific phosphodiesterase (PDE4) expression and functional sensitivity to PDE4 inhibitors among rats, monkeys and humans
H Bian et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Changes in circulating and testicular levels of inhibin A and B and activin A during postnatal development in the rat
JJ Buzzard et al.
ENDOCRINOLOGY (2004)
Cardiotoxicity in rats induced by methidathion and ameliorating effect of vitamins E and C
T Yavuz et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2004)
Tubular absorption of filtered cystatin-C in the rat kidney
AB Roald et al.
EXPERIMENTAL PHYSIOLOGY (2004)
Neutrophil gelatinase-associated lipocalin: A novel early urinary biomarker for cisplatin nephrotoxicity
J Mishra et al.
AMERICAN JOURNAL OF NEPHROLOGY (2004)
Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules
B DeSilva et al.
PHARMACEUTICAL RESEARCH (2003)
Cadmium nephrotoxicity and evacuation from the body in a rat modeled subchronic intoxication
T Aoyagi et al.
INTERNATIONAL JOURNAL OF UROLOGY (2003)
Characterisation of a potential biomarker of phospholipidosis from amiodarone-treated rats
GB Mortuza et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2003)
Urinary clusterin levels in the rat correlate with the severity of tubular damage and may help to differentiate between glomerular and tubular injuries
S Hidaka et al.
CELL AND TISSUE RESEARCH (2002)
Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis
VR Dharnidharka et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury
WK Han et al.
KIDNEY INTERNATIONAL (2002)
Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and -B as markers
Z Blumenfeld
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Comparison of plasma α glutathione S-transferase concentrations during and after low-flow sevoflurane or isoflurane anaesthesia
H Higuchi et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2001)
Urinary excretion of trypsinogen activation peptide (TAP) in taurocholate-induced pancreatitis in rats
YX Wang et al.
PANCREAS (2001)
Comparison of the diagnostic value of cardiac troponin I and T determinations for detecting early myocardial damage and the relationship with histological findings after isoprenaline-induced cardiac injury in rats
JP Bertinchant et al.
CLINICA CHIMICA ACTA (2000)
Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study
JP Neoptolemos et al.
LANCET (2000)
Urinary excretion of glutathione S transferases alpha and pi in patients with proteinuria: Reflection of the site of tubular injury
AJW Branten et al.
NEPHRON (2000)
Low serum inhibin B levels as a marker of testicular damage after treatment for a childhood malignancy
A Cicognani et al.
EUROPEAN JOURNAL OF PEDIATRICS (2000)
Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity
H Okumura et al.
ACTA HAEMATOLOGICA (2000)
Share Paper
